Antihypertensive therapy in patients above age 60. Third interim report of the European Working Party on High blood pressure in Elderly (EWPHE)
- PMID:356497
Antihypertensive therapy in patients above age 60. Third interim report of the European Working Party on High blood pressure in Elderly (EWPHE)
Abstract
Three hundred forty nine hypertensive patients above the age of 60 have entered the double-blind multicentre trial of the European Working Party on High blood pressure in the Elderly (EWPHE). After stratification and randomisation half were treated with one or two capsules containing 25 mg hydrochlorothiazide and 50 mg triamterene and if blood pressure control was insufficient methyldopa was added up to 2 g daily; the other half received matching placebo. No significant differences between the groups were present prior to randomisation. A significant blood pressure difference of 25/10 mm Hg was obtained between the groups and maintained during two years of follow-up. No major disturbances in serum potassium or serum sodium were noted with the present drug combination. However, during the initial phase an increase in serum creatinine and serum uric acid was noted in the actively treated group, which was maintained for two years. Also glucose tolerance was impaired after 2 years in the actively treated group. A favourable influence on prognosis by active treatment can be expected on the basis of the blood pressure reduction and in the absence of major electrolytes disturbances. But this benefit must be proven by observed statistical differences in terminating events between the groups. Therefore the patients are being followed for a longer period of time and more patients are admitted into the trial.
Similar articles
- Antihypertensive therapy in patients above age 60 years (Fourth Interim report of the European Working Party on High Blood pressure in Elderly: EWPHE).Amery A, Berthaux P, Birkenhäger W, Boel A, Brixko P, Bulpitt C, Clement D, De Padua F, Deruyttere M, De Schaepdryver A, Dollery C, Fagard R, Forette F, Forte J, Henry JF, Hellemans J, Koistinen A, Laaser U, Lund-Johansen P, MacFarlane J, Miguel P, Mutsers A, Nissinen A, Ohm OT, Pelemans W, Suchett-Kaye AI, Tuomilehto J, Willems J, Willemse P.Amery A, et al.Clin Sci Mol Med Suppl. 1978 Dec;4:263s-270s. doi: 10.1042/cs055263s.Clin Sci Mol Med Suppl. 1978.PMID:365433Clinical Trial.No abstract available.
- Antihypertensive therapy in patients above age 60 with systolic hypertension. A progress report of the European Working Party on High Blood Pressure in the Elderly (EWPHE).Amery A, Birkenhäger W, Bogaert M, Brixko P, Bulpitt C, Clement D, De Leeuw P, De Plaen JF, Deruyttere M, De Schaepdryver A, Fagard R, Forette F, Forte J, Hamdy R, Hellemans J, Henry JF, Koistinen A, Laaser U, Laher M, Leonetti G, Lewis P, Lund-Johansen P, MacFarlane J, Meurer K, Miguel P, Morris J, Mutsers A, Nissinen A, O'Brien E, Ohm OJ, O'Malley K, Pelemans W, Perera N, Tuomilehto J, Verschueren LJ, Willemse P, Williams B, Zanchetti A.Amery A, et al.Clin Exp Hypertens A. 1982;4(7):1151-76. doi: 10.3109/10641968209060781.Clin Exp Hypertens A. 1982.PMID:7116662Clinical Trial.
- The progress of patients in the European Working Party on Hypertension in the Elderly trial.Amery A, Beard K, Birkenhäger W, Bogaert M, Brixko P, Bulpitt C, Clement D, de Leeuw P, De Plaen JF, Deruyettere M, et al.Amery A, et al.Acta Med Scand Suppl. 1983;676:119-40.Acta Med Scand Suppl. 1983.PMID:6362343Clinical Trial.
- Antihypertensive therapy in elderly patients. Pilot trial of the European Working Party on High Blood Pressure in the Elderly.Amery A, Berthaux P, Birkenhäger W, Bulpitt C, Clement D, De Shaepdryver A, Dollery C, Ernould H, Fagard R, Forette F, Hellemans J, Kho T, Lund-Johansen P, Meurice J, Pierquin L.Amery A, et al.Gerontology. 1977;23(6):426-37. doi: 10.1159/000212219.Gerontology. 1977.PMID:330322Clinical Trial.
- Further learnings from the European Working Party on High Blood Pressure in the Elderly (EWPHE) study: focus on systolic hypertension.O'Malley K, Cox JP, O'Brien E.O'Malley K, et al.Cardiovasc Drugs Ther. 1991 Jan;4 Suppl 6:1249-51. doi: 10.1007/BF00114228.Cardiovasc Drugs Ther. 1991.PMID:2009248Review.
Cited by
- Diuretic therapy for hypertension in the elderly.Myers MG.Myers MG.Drugs. 1986;31 Suppl 4:184-91. doi: 10.2165/00003495-198600314-00022.Drugs. 1986.PMID:3732095
- Reduced peripheral vascular symptoms in elderly patients treated with alpha-methyldopa--a comparison with propranolol.VandenBurg MJ, Cooper WD, Woollard ML, Currie WJ, Bowker CH.VandenBurg MJ, et al.Eur J Clin Pharmacol. 1984;26(3):325-9. doi: 10.1007/BF00548762.Eur J Clin Pharmacol. 1984.PMID:6734693Clinical Trial.
- Hypertension in the elderly.Hutchison B.Hutchison B.Can Fam Physician. 1981 Oct;27:1579-86.Can Fam Physician. 1981.PMID:21289820Free PMC article.
- First-line drugs for hypertension.Wright JM, Musini VM, Gill R.Wright JM, et al.Cochrane Database Syst Rev. 2018 Apr 18;4(4):CD001841. doi: 10.1002/14651858.CD001841.pub3.Cochrane Database Syst Rev. 2018.PMID:29667175Free PMC article.Review.
- Effect of a new calcium antagonist, tiapamil, in hypertension of the elderly.Balansard P, Elkik F, Levenson JA, Ciampi M, Sans P.Balansard P, et al.Br J Clin Pharmacol. 1984 Dec;18(6):823-9. doi: 10.1111/j.1365-2125.1984.tb02551.x.Br J Clin Pharmacol. 1984.PMID:6529523Free PMC article.Clinical Trial.